Evidence map›Paper›PMID 19075240›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2008

The nuclear membrane organization of leukotriene synthesis.

Asim K Mandal, Phillip B Jones, Angela M Bair, Peter Christmas, Douglas Miller, Ting-ting D Yamin, Douglas Wisniewski, John Menke, Jilly F Evans, Bradley T Hyman and 5 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 104 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. cPLAScience advances · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Bioactive Lipids in MSCs Biology: State of the Art and Role in Inflammation.International journal of molecular sciences · 2021
    Review
  13. Gram-Negative BacteriaFrontiers in pharmacology · 2021
    Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Leukotrienes in Tumor-Associated Inflammation.Frontiers in pharmacology · 2020
    Review
  20. Phospholipase ABiochimica et biophysica acta. Molecular and cell biology of lipids · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Asim K MandalRenal Unit, Massachusetts General Hospital, Building 149-The Navy Yard, 13th Street, Charlestown, MA 02129, USA.
Phillip B Jones
Angela M Bair
Peter Christmas
Douglas Miller
Ting-ting D Yamin
Douglas Wisniewski
John Menke
Jilly F Evans
Bradley T Hyman
Brian Bacskai
Mei Chen
David M Lee
Boris Nikolic
Roy J Soberman
Massachusetts General Hospital · USMerck & Co., Inc., Rahway, NJ, USA (United States) · USBrigham and Women's Hospital · US

Funding

Post-transcriptional regulation of inflammatory arthritisP01AI065858 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI BRENNER, MICHAEL B. · 2006 to 2010
$11.1M
TRIGEMINOVASCULAR CONTROL OF CEREBRAL BLOOD VESSELSP50NS010828 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI LIAO, JAMES KUANG-JAN · 1985 to 2007
$10.8M
NEUROPATHOLOGICAL ALTERATIONS IN ALZHEIMERS DISEASER01AG008487 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI HYMAN, BRADLEY T. · 1995 to 2010
$5.4M
Multiphoton microscopy for in vivo neural imaging.R01EB000768 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI BACSKAI, BRIAN J · 2002 to 2015
$5.0M
Synovial Mast Cells in Inflammatory ArthritisR01AI059746 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI STEVENS, RICHARD L · 2004 to 2013
$3.3M
Pharmacology of 4F Cytochrome P450's (Supplement)R01GM061823 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI SOBERMAN, ROY · 2000 to 2003
$1.4M
Role of protein kinase Akt in cerebral ischemiaP01NS010828 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI HYMAN, BRADLEY T. · 1989 to 2008
$1.4M
INACTIVATION OF DELAYED RECTIFIER POTASSIUM CHANNELSF32NS010828 · NINDS · UNIVERSITY OF FLORIDA · PI FRAZIER, CHARLES J · 1999 to 2001
$80k
NIAID NIH HHS P01 AI065858NIAID NIH HHS R01 AI 059746NIAID NIH HHS R01 AI059746NIAID NIH HHS R01 AI068771NIAID NIH HHS R56 AI068771NIA NIH HHS 5R01 AG08487NIA NIH HHS R01 AG008487NIBIB NIH HHS 5R01 EB000768NIBIB NIH HHS R01 EB000768NIDDK NIH HHS T32 DK001540NIGMS NIH HHS 5R01 GM61823NIGMS NIH HHS R01 GM061823NINDS NIH HHS 5P50 NS010828NINDS NIH HHS F32 NS010828NINDS NIH HHS P01 NS010828NINDS NIH HHS P50 NS010828
6 · The paper itself

Abstract

Leukotrienes (LTs) are signaling molecules derived from arachidonic acid that initiate and amplify innate and adaptive immunity. In turn, how their synthesis is organized on the nuclear envelope of myeloid cells in response to extracellular signals is not understood. We define the supramolecular architecture of LT synthesis by identifying the activation-dependent assembly of novel multiprotein complexes on the outer and inner nuclear membranes of mast cells. These complexes are centered on the integral membrane protein 5-Lipoxygenase-Activating Protein, which we identify as a scaffold protein for 5-Lipoxygenase, the initial enzyme of LT synthesis. We also identify these complexes in mouse neutrophils isolated from inflamed joints. Our studies reveal the macromolecular organization of LT synthesis.

Indexed as

5-Lipoxygenase-Activating ProteinsAnimalsArachidonate 5-LipoxygenaseArthritisCarrier ProteinsLeukotrienesMembrane ProteinsMiceMultiprotein ComplexesMyeloid CellsNeutrophilsNuclear Envelope5-Lipoxygenase-Activating ProteinsAlox5ap protein, mouseArachidonate 5-LipoxygenaseCarrier ProteinsLeukotrienesMembrane ProteinsMultiprotein Complexes

Identifiers

PMID19075240
PMCPMC2629249
OpenAlexW2127810324

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.